GJA1 and breast carcinoma: In addition, the same authors [1] demonstrated that the αCT1 peptide was effective in modulating the junctional activity and distribution of Cx43 in breast cancer cells and highlighted the therapeutic potential of the αCT1 peptide in breast cancer treatment.